NCT03559296

Brief Summary

The aims of this study is to determine the inter- and intra-rater reliability of SEG and SEFS grade systems for postmastectomy lymphedema.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 6, 2018

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 18, 2018

Completed
13 days until next milestone

Study Start

First participant enrolled

July 1, 2018

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 13, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 13, 2018

Completed
Last Updated

August 23, 2018

Status Verified

August 1, 2018

Enrollment Period

1 month

First QC Date

June 6, 2018

Last Update Submit

August 21, 2018

Conditions

Keywords

imagingassessmentedemadermispostmastectomy Lymphedemareliabilityultrasoundgrade

Outcome Measures

Primary Outcomes (3)

  • International Society of Lymphology (ISL) stage by rater 1

    stage of the clinical severity of lymphedema

    Day 0

  • International Society of Lymphology (ISL) stage by rater 1

    stage of the clinical severity of lymphedema

    Day 3

  • International Society of Lymphology (ISL) stage by rater 2

    stage of the clinical severity of lymphedema

    Day 0

Secondary Outcomes (18)

  • MCP joint level affected arm

    Day 0

  • MCP joint level unaffected arm

    Day 0

  • wrist joint level affected arm

    Day 0

  • wrist joint level unaffected arm

    Day 0

  • 15 cm below the elbow joint point affected arm

    Day 0

  • +13 more secondary outcomes

Study Arms (1)

Study Group

patients with postmastectomy lymphedema who will undergo ultrasonographic assessment of postmastectomy lymphedema and circumferential tape measurement of arm

Diagnostic Test: Ultrasonographic assessment of postmastectomy lymphedema

Interventions

Qualitative assessment of postmastectomy lymphedema via ultrasound (Subcutaneous echogenicity (SEG) and subcutaneous echo-free space (SEFS) grade systems for postmastectomy lymphedema) and circumferential tape measures ( The circumferential measurement of affected arm at MCP joint, wrist joint, 15 below elbow joint, elbow joint 15cm above elbow point) to assess upper extremity volume

Study Group

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen with postmastectomy lymphedema
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Women with postmastectomy lymphedema aged 18-65 years old

You may qualify if:

  • \. Patients with unilateral postmastectomy lymphedema

You may not qualify if:

  • Bilateral lymphedema
  • The patients who had known systemic edemagenic conditions (e.g., cardiac/hepatic/renal failure, terminal cancer, on chemotherapy), and/or with cancer recurrence were excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara University School of Medicine Department of Physical Medicine and Rehabilitation

Istanbul, 34899, Turkey (Türkiye)

Location

Related Publications (1)

  • Giray E, Yagci I. Interrater and Intrarater Reliability of Subcutaneous Echogenicity Grade and Subcutaneous Echo-Free Space Grade in Breast Cancer-Related Lymphedema. Lymphat Res Biol. 2019 Oct;17(5):518-524. doi: 10.1089/lrb.2018.0053. Epub 2018 Dec 20.

MeSH Terms

Conditions

EdemaBreast Cancer Lymphedema

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsLymphedemaLymphatic DiseasesHemic and Lymphatic DiseasesPostoperative ComplicationsPathologic Processes

Study Officials

  • İlker Yagci, Prof, Msc

    Marmara University

    PRINCIPAL INVESTIGATOR
  • Esra Giray, MD

    Marmara University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 6, 2018

First Posted

June 18, 2018

Study Start

July 1, 2018

Primary Completion

August 13, 2018

Study Completion

August 13, 2018

Last Updated

August 23, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share

We don't plan to share.

Locations